Abstract
The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Protein & Peptide Letters
Title:Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Volume: 25 Issue: 7
Author(s): Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam and Mohammad Amjad Kamal*
Affiliation:
- Novel Global Community Educational Foundation, Sydney,Australia
Abstract: The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Export Options
About this article
Cite this article as:
Niazi Rasul Zahid , Khan Naqab , Khan Samiullah , Alam Mehboob and Kamal Amjad Mohammad *, Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders, Protein & Peptide Letters 2018; 25 (7) . https://dx.doi.org/10.2174/0929866525666180614120407
DOI https://dx.doi.org/10.2174/0929866525666180614120407 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insights into Anti-Trypanosomal Agents Based on Synthetic Glycoconjugates
Current Topics in Medicinal Chemistry Effects of Chronic Lamotrigine Administration on Maximal Electroshock- Induced Seizures in Mice
CNS & Neurological Disorders - Drug Targets Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
Current Medicinal Chemistry Editorial [ Hot Topic: Recent Advances in Pediatric Epilepsy Surgery (Guest Editor: Batool F. Kirmani)]
Current Pediatric Reviews Preface:
Current Topics in Medicinal Chemistry Organic Lesions in the Brain MRI of Children with Febrile Seizure
Current Medical Imaging Recent Advances in Epilepsy
Current Neuropharmacology Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety The Effect of Protein Restriction in the In Vitro Metabolism of Albendazole in Rats
Drug Metabolism Letters Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies Conference Report: Summary Report of the International Association of Neurorestoratology VII Conference: Regulations, Ethics, Science, and the Need of Patients Care in Neurorestoratology
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]
Current Pharmaceutical Design Therapeutic Strategies for Treatment of Inflammation-related Depression
Current Neuropharmacology Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders
Mini-Reviews in Medicinal Chemistry Crosstalk between Inflammation and the BBB in Stroke
Current Neuropharmacology PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design Clinical, Immunological and Therapeutic Aspects of Autoimmune Encephalitis
Recent Patents on CNS Drug Discovery (Discontinued) The Treatment of Painful Diabetic Neuropathy
Current Diabetes Reviews Mechanisms Underlying Anti-hyperalgesic Properties of Kaempferol-3,7- di-O-α-L-rhamnopyranoside Isolated from Dryopteris cycadina
Current Topics in Medicinal Chemistry Current Research on Opioid Receptor Function
Current Drug Targets